Dr. Rami Manochakian is a board-certified medical oncologist who specializes in thoracic malignancies. Lung cancer and pleural mesothelioma patients seeking care at the Mayo Clinic in Florida benefit from his experience, knowledge, and extensive research of thoracic malignancies of all types. He is particularly focused on the treatment of non-small cell lung cancer (NSCLC), small
Dr. Aaron S. Mansfield is a Mayo Clinic medical oncologist who practices and conducts research at the Rochester, Minnesota site. As co-director of the Precision Cancer Therapeutics Program within the Mayo Clinic Center for Individualized Medicine, he has played a significant role in the development of new treatments for lung cancer and other thoracic malignancies,
Dr. Mohamed Shanshal is a medical oncologist at the Mayo Clinic in Rochester, Minnesota. As a member of both the Oncology department and the Lung Cancer Program, he is focused on treating patients with thoracic malignancies, including mesothelioma and lung cancer. He is also working on the development of novel drug therapeutics for these illnesses
Dr. Mathew Thomas is the Director of Thoracic Surgery and Chair of Robotic Surgery at Mayo Clinic in Florida. His primary interest lies in improving and advancing the use of minimally invasive surgical techniques for the treatment of chest malignancies, including lung cancer and malignant pleural mesothelioma. Dr. Thomas is skilled in the use of
Dr. Dennis Wigle is a thoracic surgeon and researcher at the Mayo Clinic in Rochester, Minnesota. As Chief of the Division of Thoracic Surgery, his focus is on understanding and treating lung cancer, esophageal cancer, and other thoracic malignancies including malignant pleural mesothelioma. Dr. Wigle has years of experience in a wide range of surgical
For asbestos-exposed individuals, the specter of mesothelioma is always lurking in the background. Every cough or discomfort raises alarm bells that it could be the first sign of a deadly diagnosis. Researchers have been exploring the utility of a screening breath test to help allay these fears and provide an early detection tool. They reported on their
Dr. Giuseppe Giaccone ranks among the world’s most highly respected practitioners in the treatment and study of lung cancer and in developmental therapeutics. He is a medical oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital and serves as Chief of Thoracic Oncology and Associate Director for Clinical Research at the Sandra and Edward Meyer Cancer
Back in 2009, the International Association for the Study of Lung Cancer presented a model they’d developed to help stage malignant mesothelioma cases. Since then, additional data has been added to the model’s database to continue enhancing its accuracy. This week, the group’s members attending its annual conference in Singapore learned that the model is
Dr. Stephen Liu’s clinical practice focuses on thoracic malignancies, including lung cancer, thymic malignancies, and pleural cancers including malignant pleural mesothelioma. He has significant expertise in the development of novel therapeutic agents and in combining treatment protocols with the goal of improving patient outcomes. Dr. Liu’s philosophy of care is in alignment with the mission
Dr. Frank Detterbeck is board-certified in general surgery as well as in thoracic and cardiac surgery. As Chief of Thoracic Surgery at Yale Cancer Center, he has earned a national reputation for performing minimally invasive surgeries for the treatment of lung cancer, malignant mesothelioma, and other thoracic malignancies and life-threatening diseases. In addition to valuing